| Dr Dawne Pflughoeft, DDS | |
|
Cmr 414 Box 2717, Apo, AE 09173-9998 | |
| (094) 728-31720 | |
| Not Available |
| Full Name | Dr Dawne Pflughoeft |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | Cmr 414 Box 2717, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265598072 | NPI | - | NPPES |
| 092518700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | D8676 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dawne Pflughoeft, DDS Cmr 414 Box 2717, Apo, AE 09173-9998 Ph: () - | Dr Dawne Pflughoeft, DDS Cmr 414 Box 2717, Apo, AE 09173-9998 Ph: (094) 728-31720 |
News Archive
Jesse Stewart, Ph.D., assistant professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis and an Indiana University Center for Aging Research affiliated scientist, has received a $110,000 grant from the American Heart Association to explore whether treatment of depression before one experiences a heart attack can reduce the likelihood of future heart disease.
Incidence of cervical cancer in young women is set to decline 75 percent by 2040 with deaths close to eradicated, however older women will face greater risk according to research led by Queen Mary University of London, published today in The Lancet Public Health.
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.
Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein therapies to treat cardiovascular and metabolic diseases, today announced the start of the Phase 2 CHI-SQUARE study of CER-001 in patients with acute coronary syndrome.
Enobia Pharma Inc. unveiled findings from the first hypophosphatasia self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics Annual Clinical Genetics Meeting.
› Verified 2 days ago
Dr. Jameson Everett Hoffman, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Panzer Kaserne Bldg 2996, Apo, AE 09046 Phone: 314-590-1664 Fax: 314-590-2881 | |
Dr. Nicholas Ruana, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Area Support Group - Kuwait, Dental, Apo, AE 09366 Phone: 702-217-7343 | |
Dr. Minaxi I Patel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Unit 26610, Wuerzburg Dental Activity Credentials Office, Apo, AE 09244 Phone: 931-804-3933 | |
Dr. Courtney L Ho, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Dental Activity Credentials Office, Cmr 402, Apo, AE 09180 Phone: 011-496-371929130 Fax: 011-496-371929117 | |
Terrence O'neal Lewis, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Us Army Dentac Bavaria, Unit 28038, Apo, AE 09112 Phone: 314-590-3980 | |
Dr. Colin Gartner, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461 Phone: 011-441-6385 | |
Dr. Richard Allen Mcclure, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg, Unit 3215, Apo, AE 09094 Phone: 314-479-2609 |